News
-
-
PRESS RELEASE
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Quantum BioPharma starts sentinel dosing for Lucid-21-302 trial in multiple sclerosis treatment. Corporate update includes engaging ITG, Buyins, and Stockjock for Investor Relations Activities -
-
PRESS RELEASE
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Quantum BioPharma files $700M lawsuit against CIBC, RBC for market manipulation schemes. Press release details legal action and evidence. Law firms Christian Attar and Freedman Normand Friedland LLP to take the case on a contingency basis -
-
PRESS RELEASE
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Christian Attar Law Firm and Freedman Normand Friedland LLP, with forensic investigators, uncover multi-year market manipulation scheme by CIBC, RBC, and others causing $700 Million damage to Quantum BioPharma Ltd -
-
PRESS RELEASE
Quantum BioPharma Ltd. Pharma Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group Across Puerto Rico, the Caribbean, and Parts of Central and South America
Celly Nutrition Corp. partners with FUSION Distribution Group to bring unbuzzd™, an alcohol metabolism supplement, to new markets. The innovative beverage promotes alertness and is available in RTM powder sticks and RTD 12oz cans -
-
